openPR Logo
Press release

Vascular Closure Device (VCD) Market Growth and Development for Global Regions 2017-2022 | Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc

02-25-2019 03:19 PM CET | Health & Medicine

Press release from: Future Market Insights

Vascular Closure Device (VCD) Market Growth and Development

Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of 5.9%, and reach US$ 963 million over the forecast period, 2017-2022. Compared to manual compression techniques, vascular closure devices play a key role in lowering undue complications such as bleeding.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1809

However, increasing use of transradial arterial access, the continued requirement for post-procedure bed rest, significant costs, and device deployment complexities are observed as key deterrents for adoption of vascular closure devices. The use of VCDs is also anticipated to be influenced by a significant increase in the number of outpatient PCI procedures and the desire of patients to avoid arterial cut-down procedures. According to the report, hospitals will be the largest end-users of vascular closure devices in the next five years. By the end of 2022, over US$ 600 million revenues are anticipated to be procured globally from the end-use of vascular closure devices in hospitals.

Clip-based VCDs to Register 6% CAGR through 2022

A key insight from the report reveals that the demand for clip-based vascular closure devices will be relatively higher than compression devices and haemostasis pads. Despite the latter being top-selling products in the global vascular closure devices market, clip-based VCDs are expected to outpace them in terms of demand over the next five years. From medical standpoint, many surgeons prefer VCDs designed with active approximators that can physically close the arteriotomy by using nitinol clips. These metallic clips can also restrict MRI scanners from capturing the unnecessary structures which are immediately adjacent to the arteriotomy. These clip-based VCDs can boost procedural efficiency as well as post-procedural diagnostics for a wide range of cardiovascular treatments.

North America to Exhibit Steadfast Adoption of Vascular Closure Devices

A regional analysis provided in the report reveals North America as the largest market for vascular closure devices. The region is anticipated to remain at the forefront of global expansion of vascular closure devices market through 2022. Robust healthcare marketplaces in the US, coupled with consumer lifestyles that have surged the incidence of cardiac disorders, will continue to boost North America’s presence in the global vascular closure devices market. The report also projects that Asia-Pacific excluding Japan (APEJ) region will register fastest growth in its vascular closure devices market, and rake over US$ 145 million by the end of 2022.

Request Customized Copy of this Report @ https://www.futuremarketinsights.com/customization-available/rep-gb-1809

Companies to Watch

Companies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market. In the near future, several manufacturers of vascular closure devices will be focusing on reducing the existing drawbacks of using VCDs, which include extended hospitalisation, high morbidity risks, and the need for administering antibiotics. Some companies will also be focusing on advancing their umbrella on VCD technologies and improving the quality of life for patients being treated through vascular closure devices.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Blog: http://www.marketresearchblog.org/

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vascular Closure Device (VCD) Market Growth and Development for Global Regions 2017-2022 | Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc here

News-ID: 1614615 • Views:

More Releases from Future Market Insights

Glucuronolactone Market Forecast 2026-2036: Global Market to Reach USD 698.0 Million by 2036 at 8.0% CAGR
Glucuronolactone Market Forecast 2026-2036: Global Market to Reach USD 698.0 Mil …
The global functional beverage ecosystem is entering a new phase of ingredient-driven innovation. As consumers increasingly seek solutions to combat fatigue, boost cognitive performance, and support overall wellness, the Glucuronolactone Market is witnessing strong expansion. Valued at USD 298.8 million in 2025, the market is projected to grow to USD 322.7 million in 2026 and ultimately reach USD 698.0 million by 2036, registering a robust CAGR of 8.0% during the
Genetically Modified Food Market Forecast 2026-2036: Global Market to Reach USD 269.6 Billion by 2036 at 7.4% CAGR
Genetically Modified Food Market Forecast 2026-2036: Global Market to Reach USD …
The global genetically modified food market is entering a phase of accelerated technological adoption as agricultural biotechnology becomes central to ensuring global food security. According to the latest analysis by Future Market Insights (FMI), the market crossed a valuation of USD 123.4 billion in 2025 and is expected to reach USD 132.5 billion in 2026. Over the next decade, the market is projected to expand significantly, reaching USD 269.6 billion
Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast 2026-2036: Market to Reach USD 1,647.6 Million by 2036 at 4.2% CAGR
Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast 2026-2036: Mark …
NEWARK, DE | The Magnetic Resonance Imaging (MRI) Contrast Agents Market was valued at USD 1,091.9 million in 2026 and is projected to reach USD 1,647.6 million by 2036, expanding at a CAGR of 4.2% during the forecast period. The projected absolute dollar growth of USD 555.7 million reflects steady, protocol-led expansion rather than cyclical volatility, underpinned by stable MRI scan volumes and safety-governed procurement across hospitals and imaging networks. As
Freeze Drying Market Forecast 2026-2036: Market to Reach USD 3,142.3 Million by 2036 at 7.1% CAGR
Freeze Drying Market Forecast 2026-2036: Market to Reach USD 3,142.3 Million by …
NEWARK, DE | The global Freeze Drying Market was valued at USD 1,582.5 million in 2026 and is projected to reach USD 3,142.3 million by 2036, expanding at a CAGR of 7.1%. Absolute dollar growth of USD 1,672.1 million over the decade signals structural scale-up driven by sterile manufacturing expansion and increasing use of lyophilisation for stability-sensitive products. As per Future Market Insights (FMI), demand is anchored in aseptic manufacturing workflows,

All 5 Releases


More Releases for VCD

Angiography Surgery Vascular Closure Device (VCD) Market to Set Phenomenal Growt …
The global angiography surgery vascular closure device (VCD) market is valued at approximately $1.5 billion in 2024. Projections indicate substantial growth, with the market expected to reach around $3.1 billion by 2034. This represents a notable Compound Annual Growth Rate (CAGR) of approximately 7.6% during the forecast period from 2025 to 2034. Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in
Vascular Closure Device (VCD) Market offers the most expected scenario to help c …
Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for Vascular Closure Devices will expand steadily at a CAGR of
Vascular Closure Device (VCD) Market Size Worth US$ 963 Million by 2022 | Arstas …
Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of
Vascular Closure Device (VCD) Market to expand at a CAGR of 5.9% by 2022
Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of
Global and Chinese Home DVD & VCD Player Industry: Market Size, Analysis, News s …
Latest industry research report on: Global and Chinese Home DVD & VCD Player Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/1160882 The 'Global and Chinese Home DVD & VCD Player Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Home DVD & VCD Player industry with a focus on
Vascular Closure Devices (VCD) Market 2015-2022 Growth Trends and Forecasts
The new research report on Vascular Closure Devices (VCD) Market offered by DecisionDatabases.com provides Global Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2022. Get FREE Sample Report Copy @ http://www.decisiondatabases.com/contact/download-sample-12746 The report on global vascular closure devices (VCD) market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the